Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

Journal of Pharmaceutical Policy and Practice

Christine Y Lu¹  Dennis Ross-Degnan¹  Anita K Wagner¹  Peter Stephens¹  Isabel Cristina M Emmerick¹ 

[1] Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, USA

关键词: Diabetes;    Brazil;    China;    Thailand;    Drug policy;    Insulin;    Oral hypoglycemic agents;    Access to medicines;   

DOI  :  10.1186/s40545-014-0020-4

学科分类：药理学

来源: BioMed Central

【 摘 要 】

Objectives

New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: Brazil, China, and Thailand.

【 授权许可】

Unknown